| Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population FS Vahidy, JC Nicolas, JR Meeks, O Khan, A Pan, SL Jones, F Masud, ... BMJ open 10 (8), e039849, 2020 | 257 | 2020 |
| Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area FS Vahidy, AP Pan, H Ahnstedt, Y Munshi, HA Choi, Y Tiruneh, K Nasir, ... PloS one 16 (1), e0245556, 2021 | 228 | 2021 |
| Biomarkers for PD-1/PD-L1 blockade therapy in non–small-cell lung cancer: Is PD-L1 expression a good marker for patient selection? YK Chae, A Pan, AA Davis, K Raparia, NA Mohindra, M Matsangou, ... Clinical lung cancer 17 (5), 350-361, 2016 | 129 | 2016 |
| Association of tumor mutational burden with DNA repair mutations and response to anti–PD-1/PD-L1 therapy in non–small-cell lung cancer YK Chae, AA Davis, K Raparia, S Agte, A Pan, N Mohindra, V Villaflor, ... Clinical lung cancer 20 (2), 88-96. e6, 2019 | 109 | 2019 |
| Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non‐small cell lung cancer YK Chae, AA Davis, S Agte, A Pan, NI Simon, WT Iams, MR Cruz, ... The oncologist 24 (6), 820-828, 2019 | 107 | 2019 |
| Path toward precision oncology: review of targeted therapy studies and tools to aid in defining “actionability” of a molecular lesion and patient management support YK Chae, AP Pan, AA Davis, SP Patel, BA Carneiro, R Kurzrock, FJ Giles Molecular Cancer Therapeutics 16 (12), 2645-2655, 2017 | 84 | 2017 |
| Contemporary trends in the nationwide incidence of primary intracerebral hemorrhage AT Bako, A Pan, T Potter, J Tannous, C Johnson, E Baig, J Meeks, D Woo, ... Stroke 53 (3), e70-e74, 2022 | 29 | 2022 |
| Comparison of tumor mutational burden (TMB) across tumor tissue and circulating tumor DNA (ctDNA). AA Davis, YK Chae, S Agte, A Pan, NI Simon, TJ Taxter, A Behdad, ... Journal of Clinical Oncology 35 (15_suppl), e23028-e23028, 2017 | 28 | 2017 |
| Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC). AA Davis, YK Chae, S Agte, A Pan, NA Mohindra, VM Villaflor, FJ Giles Journal of Clinical Oncology 35 (7_suppl), 24-24, 2017 | 28 | 2017 |
| Recent advances and future strategies for immune-checkpoint inhibition in small-cell lung cancer YK Chae, A Pan, AA Davis, N Mohindra, M Matsangou, V Villaflor, F Giles Clinical Lung Cancer 18 (2), 132-140, 2017 | 27 | 2017 |
| Disparities in COVID-19 hospitalizations and mortality among black and Hispanic patients: cross-sectional analysis from the greater Houston metropolitan area AP Pan, O Khan, JR Meeks, ML Boom, FN Masud, JD Andrieni, ... BMC Public Health 21, 1-13, 2021 | 25 | 2021 |
| Cognitive impairment after intracerebral hemorrhage: a systematic review of current evidence and knowledge gaps T Potter, VA Lioutas, M Tano, A Pan, J Meeks, D Woo, S Seshadri, ... Frontiers in neurology 12, 716632, 2021 | 25 | 2021 |
| Rapid response to drive COVID-19 research in a learning health care system: rationale and design of the Houston Methodist COVID-19 surveillance and outcomes registry (curator) F Vahidy, SL Jones, ME Tano, JC Nicolas, OA Khan, JR Meeks, AP Pan, ... JMIR medical informatics 9 (2), e26773, 2021 | 22 | 2021 |
| Real world effectiveness of COVID-19 mRNA vaccines against hospitalizations and deaths in the United States FS Vahidy, L Pischel, ME Tano, AP Pan, ML Boom, HD Sostman, K Nasir, ... Medrxiv, 2021.04. 21.21255873, 2021 | 19 | 2021 |
| SARS-CoV-2 susceptibility and COVID-19 mortality among older adults with cognitive impairment: cross-sectional analysis from hospital records in a diverse US metropolitan area AP Pan, J Meeks, T Potter, JC Masdeu, S Seshadri, ML Smith, MG Ory, ... Frontiers in Neurology 12, 692662, 2021 | 17 | 2021 |
| Sex differences in post-stroke cognitive decline: A population-based longitudinal study of nationally representative data AT Bako, T Potter, J Tannous, AP Pan, C Johnson, E Baig, B Downer, ... Plos one 17 (5), e0268249, 2022 | 11 | 2022 |
| Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry … J Tannous, AP Pan, T Potter, AT Bako, K Dlouhy, A Drews, HD Sostman, ... BMJ open 13 (4), e067611, 2023 | 10 | 2023 |
| COVID‐19 associated disruptions in routine health care of people with mild cognitive impairment or dementia J Tannous, A Pan, A Bako, T Potter, SL Jones, N Janjan, ML Smith, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 8 | 2022 |
| Association of circulating tumor DNA (ctDNA) tumor mutational burden (TMB) with DNA repair mutations and response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer (NSCLC). AA Davis, YK Chae, S Agte, A Pan, WT Iams, MRDS Cruz, NA Mohindra, ... Journal of Clinical Oncology 35 (15_suppl), 11537-11537, 2017 | 8 | 2017 |
| Real world evidence of effectiveness of COVID-19 vaccines and anti SARS-CoV-2 monoclonal antibodies against post-acute sequelae of SARS-CoV-2 infection J Tannous, AP Pan, T Potter, A Bako, K Dlouhy, A Drews, HD Sostman, ... Medrxiv, 2022.06. 30.22277105, 2022 | 7 | 2022 |
